Living drugs that reprogram patients’ immune cells show early promise against hard-to-treat brain tumors
CNN —
For decades, a diagnosis of glioblastoma – an aggressive, hard-to-treat cancer in the brain – has been a death sentence for patients.
Only 3% to 5% of people who are diagnosed with this type of brain tumor will be alive three years later. On av... [9459 chars]
Source: CNN
